✦ LIBER ✦

A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients with Relapsed or Refractory Multiple Myeloma

✍ Scribed by Berenson, James R.; Swift, Regina A.; Ferretti, Delina; Purner, Matthew B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of melphalan, arseni

✍ James R. Berenson; Ralph Boccia; David Siegel; Marek Bozdech; Alberto Bessudo; E 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Efficacy of melphalan, arsenic trioxide,

✍ Borad, M J; Swift, R; Berenson, J R 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

A Prospective, Open-Label Safety and Eff

✍ Yang, Hank H.; Vescio, Robert; Schenkein, David; Berenson, James R. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB

Phase 2 study of arsenic trioxide in pat

✍ Mohamad A. Hussein; Mansoor Saleh; Farhad Ravandi; James Mason; Robert M. Rifkin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Efficacy and safety results with the com

✍ Rony M. Abou-Jawde; Janice Reed; Megan Kelly; Esteban Walker; Steven Andresen; R 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 172 KB

Safety and efficacy of bortezomib and me

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB